Midostaurin April 12, 2017 Midostaurin Trade Name Orphan Indication Acute myeloid leukemia USA Market Approval USA USA Designation Date 2009-07-07 00:00:00 Sponsor Novartis Pharmaceuticals Corporation;One Health Plaza;East Hanover, New Jersey, 07936
